GPX4 and cancer: To cope with this characteristic, the expression of GSH or Nrf2 in malignant cells is upregulated to maintain a balanced level of ROS, which helps them to avoid ferroptosis, but it also results in the ferroptosis vulnerability of cancer cells will increase significantly when the GSH-GPX4 pathway is blocked (Kennedy et al., 2020).